Cantor Fitzgerald Maintains Overweight on Eli Lilly, Raises Price Target to $815
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald analyst Louise Chen maintains an Overweight rating on Eli Lilly (LLY) and raises the price target from $630 to $815, indicating a positive outlook on the company's stock.
February 06, 2024 | 7:43 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cantor Fitzgerald analyst Louise Chen maintains an Overweight rating on Eli Lilly and raises the price target from $630 to $815.
The increase in price target from $630 to $815 by a reputable analyst suggests a strong confidence in Eli Lilly's future performance. This significant adjustment reflects expectations of robust growth or positive developments within the company, likely leading to increased investor confidence and potential short-term price appreciation.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100